PubMed COVID-19 Clinical Care
14251 - 14260 of 57753 results found
Influence of scan duration on dynamic contrast -enhanced magnetic resonance imaging pharmacokinetic parameters for brain lesions
Description
CONCLUSION: K(ep) and V(e) were time-dependent in brain tumors, so a longer scan time is needed to obtain reliable parameter values. K^(trans) was found to be time-independent, as it remains the same in all 6 acquisition times and is the only
Immunothrombosis and complement activation contribute to disease severity and adverse outcome in COVID-19
Description
Severe COVID-19 is characterized by systemic inflammation and multiple organ dysfunction syndrome (MODS). Arterial and venous thrombosis are involved in the pathogenesis of MODS and fatality in COVID-19. There is evidence that complement - and
Burnout and turnover intention of primary health care providers during the COVID-19 pandemic in China
Description
CONCLUSIONS: Results from this study have highlighted the importance of paying attention to vulnerable groups of PHC providers, for example those who are separated from their families, during emergency situations. Various incentive tools could be
The prediction of main protease SARS-CoV-2 inhibition based on models of enzyme-inhibitor complexes
Description
A set of linear regression equations predicting the IC50 values for SARS-CoV-2 main protease inhibitors was analyzed. For 180 competitive inhibitors, we have simulated the molecular dynamics of enzyme-inhibitor complexes with known structures or
The Impact of COVID-19 on Outcomes of Ischemic Colitis: A Nationwide Retrospective Analysis
Description
CONCLUSIONS: Among hospitalized patients with ischemic colitis, COVID-19 infection was associated with worse outcomes and higher resource utilization. Further studies are needed to investigate the mechanisms underlying this association.
Development of telemedicine in the Czech Republic from patients' and other key stakeholders' perspective
Description
Telemedicine is a way to improve healthcare outcomes with greater efficiency for both patients and care providers. The great potential of digital technologies also lies in strengthening the patient-centered approach. The early successes and benefits
Multi-omics for COVID-19: driving development of therapeutics and vaccines
Description
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised global concern for public health and economy. The development of therapeutics and vaccines to combat this virus is continuously progressing. Multi-omics approaches, including genomics
How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study
Description
CONCLUSION: Among patients with COVID-19 patients, immune breakthroughs resulting from previous infection or vaccination, could decelerate disease progression and enhance prognosis by expediting host cellular and humoral immunity to accelerate virus
Construct and criterion validity of muscle ultrasonography for assessment of skeletal muscle in patients recovering from COVID-19
Description
Background: The purpose was to investigate the content, construct, and criterion validity of muscle ultrasound in a mixed cohort of participants recovering from mild and critical COVID-19. Methods: A secondary analysis of a prospective cross
